Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Ebola Health Lessons: A Wake-up Call

November 6, 2014 12:02 pm | by Stephanie Guzowski, Editor | Articles | Comments

After months of delayed, fragmented responses, the international medical community recognized Ebola as a threat to global health security. Here’s where the situation stands today as well as questions raised and lessons learned. Read more… 

TOPICS:

Creation of Montreal Pharma Company for $6.4M

November 6, 2014 9:49 am | News | Comments

The IRCM just signed an agreement with a leading international investment firm, Sanderling Ventures, to create Liphorus Pharmaceuticals. Up to $6.4 million will be invested in the new spinoff company in the coming years. Read more...

TOPICS:

Generic Prilosec Gets Final ANDA Approval

November 6, 2014 9:44 am | News | Comments

Glenmark Generics Inc. USA, has been granted final approval for its abbreviated new drug application (ANDA) from the FDA for Omeprazole Delayed Release Capsules, their generic version of Prilosec by AstraZeneca. Read more...

TOPICS:
Advertisement

New Drug Inhibits Cancer Tumor Growth

November 6, 2014 9:38 am | News | Comments

Manchester scientists have shown that a new drug inhibits the growth of tumors in the lab and that its effectiveness is improved by combining it with radiotherapy – suggesting a new approach that could be used in the clinic. Read more...

TOPICS:

FDA Approves Janssen's Hep C Drug

November 6, 2014 9:26 am | News | Comments

Janssen Therapeutics, Division of Janssen Products, LP (Janssen) announced the U.S. Food and Drug Administration (FDA) has approved Olysio(simeprevir), a hepatitis C virus (HCV) NS3/4A protease inhibitor, in combination with sofosbuvir as an all-oral, interferon- and ribavirin-free treatment option for genotype 1 chronic hepatitis C (CHC) infection in adult patients. Read more...

TOPICS:

Perrigo Acquires Omega Pharma for $4.5B

November 6, 2014 9:12 am | News | Comments

Perrigo Company plc, a leading global provider of "Quality Affordable Healthcare Products," and Omega Pharma NV, one of the largest OTC healthcare companies in Europe, headquartered in Nazareth, Belgium, announced that they have entered into a definitive agreement with Perrigo. Read more...

TOPICS:

Allergan Deal Inches Forward with Court's Decision

November 5, 2014 2:26 pm | News | Comments

In a win for Valeant and Pershing Square, a federal judge has decided that they can vote in takeover target Allergan's upcoming shareholder meeting. Read more...

TOPICS:

Roche to Invest $470M on Diagnostics

November 5, 2014 2:14 pm | News | Comments

Roche announced it will invest 450 million Swiss Francs ($470 million) over the next three years to establish a new diagnostic manufacturing facility at the Suzhou Industrial Park, in Suzhou, China. Read more...

TOPICS:
Advertisement

Ebola Hits Health Care Access for Other Diseases

November 5, 2014 2:07 pm | by Jonathan Paye-Layleh and Sarah DiLorenzo – Associated Press | News | Comments

The Ebola outbreak has spawned a "silent killer," experts say: hidden cases of malaria, pneumonia, typhoid and the like that are going untreated because people in the countries hardest hit by the dreaded virus either cannot find an open clinic or are too afraid to go to one. Read more...

TOPICS:

Signaling Pathway Leads to Obesity

November 5, 2014 1:58 pm | News | Comments

As scientists probe the molecular underpinnings of why some people are prone to obesity and some to leanness, they are discovering that weight maintenance is more complicated than the old “calories in, calories out” adage. Read more...

TOPICS:

Genetic Markers Discovered for Alcoholism Recovery

November 5, 2014 1:46 pm | News | Comments

In an international study, Mayo Clinic researchers and collaborators have identified genetic markers that may help in identifying individuals who could benefit from the alcoholism treatment drug acamprosate. Read more...

TOPICS:

China Factory Whirs Overtime to Make Ebola Suits

November 5, 2014 1:39 pm | by Zhang Weiqun - Associated Press | News | Comments

The sewing and gluing machines at a factory in China have been whirring more than usual to produce the crucial yellow suits that protect the front-line medics from ebola in West Africa. Read more...          

TOPICS:

AFib Blood Thinner Has Higher GI Risk

November 5, 2014 1:33 pm | News | Comments

Patients with atrial fibrillation who take the blood thinner dabigatran are at greater risk for major bleeding and gastrointestinal bleeding than those who take warfarin, according to a new study by researchers at the University of Pittsburgh Graduate School of Public Health. Read more...

TOPICS:

Melanoma Survival Better With Immune Booster

November 5, 2014 1:11 pm | News | Comments

Patients with metastatic melanoma who were treated with ipilimumab, an immune checkpoint blocker, survived 50% longer – a median 17.5 months vs. 12.7 months – if they simultaneously received an immune stimulant, according to a study led by Dana-Farber Cancer Institute scientists. Read more...

TOPICS:

Astellas' Fungal Treatment Gets Orphan Drug Designation

November 5, 2014 10:43 am | News | Comments

Astellas announced that the FDA granted orphan drug designation to isavuconazole for the treatment of invasive candidiasis. Read more...                     

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading